Explore cutting-edge research and treatment developments in multiple myeloma through this 45-minute medical lecture delivered by Dr. Ken Anderson, highlighting key findings from the 2022 American Society of Hematology Annual Meeting and providing comprehensive insights into current therapeutic approaches and clinical advancements in the field of multiple myeloma treatment.
Overview
Syllabus
Update in Multiple Myeloma
Taught by
Dana-Farber Cancer Institute
Related Courses
-
Updates in Multiple Myeloma in 2024 - From Bench to Bedside
-
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma
-
Continued Evolution of Therapy for Patients with Newly Diagnosed Multiple Myeloma
-
ON DEMAND: Yale’s Review of Advances in Oncology Highlights from the ASCO® Annual Meeting 2021
-
Future of Novel Next-Generation Therapy in the Management of Relapsed/Refractory Multiple Myeloma
-
Early Detection and Prevention of Multiple Myeloma Progression
